GlaxoSmithKline S.A.E (CASE: BIOC)
Health Care · Pharmaceuticals · EG
EGP350.11
+36.94% today · +464.2% 1Y
GlaxoSmithKline S.A.E (CASE: BIOC) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $558.53M.
Over the last twelve months the share price has gained 464.2%, trading between 55.10 and 609.00.
Tweenvest scores GlaxoSmithKline S.A.E across four factors: quality 74/100, value 34/100, growth 59/100, dividend 44/100. Its strongest factor is quality.
BIOC price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $558.53M
- Revenue (TTM)
- $73.64M
- P/E
- 150.58
- EPS
- 2.33
- Dividend yield
- 0.21%
- Beta (5Y)
- 0.28
- 52-week high
- EGP609.00
- 52-week low
- EGP55.10
- Avg volume (3M)
- —
- Shares outstanding
- 83.51M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| CorMedix Inc.NasdaqGM: CRMD | $567.43M | $7.23 | -0.69% |
| FDC LimitedBSE: 531599 | $567.41M | Rs335.55 | -1.61% |
| Kingchem (Liaoning) Life Science Co., Ltd.SZSE: 301509 | $561.13M | CN¥31.25 | +0.19% |
| Huaren Pharmaceutical Co., Ltd.SZSE: 300110 | $558.70M | CN¥3.17 | -8.12% |
| Nanjing Hicin Pharmaceutical Co., Ltd.SZSE: 300584 | $557.80M | CN¥31.18 | +3.11% |
| Zhuhai Rundu Pharmaceutical Co., Ltd.SZSE: 002923 | $550.68M | CN¥11.03 | +1.66% |
| Phathom Pharmaceuticals, Inc.NasdaqGS: PHAT | $549.66M | $6.80 | -1.73% |
| Clarity Pharmaceuticals LtdASX: CU6 | $544.53M | AU$2.10 | -0.47% |
Figures last refreshed Oct 4, 2026.